Clinical Significance of Serum Concentrations of Advanced Oxidation Protein Products and Advanced Giycation End Products in Patients with Acute Coronary Syndrome

谭德安,府伟灵,张波,张鸣,罗胜权,马双双
DOI: https://doi.org/10.3969/j.issn.1006-3110.2007.01.022
2007-01-01
Abstract:Objective To explore the serum concentrations of advanced oxidation protein products (AOPP) and advanced glycation end products (AGE) in acute coronary syndrome(ACS)and their influences to prognosis of ACS. Methods The serum concentrations of AOPP and AGE were measured by using spectrophotometer and enzyme linked immunosorbent assay in 29 patients with NSTEMI/UA and 26 patients with STEMI (ACS group) and 30 healthy subjects (control group). Results There were significant differences in the serum levels of AOPP and AGE between the ACS group and the control group(P0.01). The serum levels of AOPP and AGE in STEMI group were higher than those of NSTEMI/UA group(P0.05), and there were significant differences in STEMI group with simplex between multitude process coronary artery (P0.05). Conclusion AOPP and AGE are closely associdted with ACS, and they are both regarded as the indications for the prognosis of ACS.
What problem does this paper attempt to address?